>北美制药隔离器市场，按类型（无菌隔离器、遏制隔离器、生物隔离器、取样和称重隔离器、活性药物成分 (API) 制造隔离器、放射性药物隔离器、生产隔离器等）、系统类型（封闭系统、开放系统）、压力（正压、负压）、配置（落地式、模块化、移动式、紧凑式、台式、便携式、其他）、应用（无菌测试、制造、取样/称重/分配、医疗器械制造）、最终用户（医院、诊断实验室、学术和研究机构、制药和生物技术公司、合同研究组织等）、分销渠道（直接招标、零售销售、第三方分销商）行业趋势和预测到 2029 年。
北美制药隔离器市场分析与洞察
制药隔离器在制药行业中用作无污染屏障系统。微生物检测、细胞疗法处理、先进制药 (ATMP) 制造以及无菌注射产品的称重、包装和分销只是制药隔离器的几种应用。发展中国家和发达国家制药市场的持续增长以及用于生产创新疗法的研发支出的增加推动了制药隔离器的使用。先进的医疗绝缘体和制药行业的要求促使主要制造商发展医疗绝缘体行业。危险化合物的使用增加、不合规成本的增加以及研究实验室的增加是预测期内推动制药隔离器市场发展的重要驱动因素。
然而，大多数专家不认为监管机构不再阻碍药物绝缘体开发等突破。
Data Bridge Market Research 分析称，预计到 2029 年，北美制药隔离器市场价值将达到 26.2764 亿美元，预测期内复合年增长率为 14.6%。由于该地区对制药隔离器的需求迅速增长，类型占据了市场中最大的类型部分。本市场报告还深入介绍了定价分析、专利分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按类型（无菌隔离器、密闭隔离器、生物隔离器、取样和称重隔离器、活性药物成分 (API) 制造隔离器、放射性药物隔离器、生产隔离器、其他）、系统类型（封闭系统、开放系统）、压力（正压、负压）、配置（落地式、模块化、移动式、紧凑式、台式、便携式、其他）、应用（无菌测试、制造、取样/称重/分配、医疗器械制造）、最终用户（医院、诊断实验室、学术和研究机构、制药和生物技术公司、合同研究组织、其他）、分销渠道（直接招标、零售、第三方分销商）。 |
|
覆盖国家 |
美国、加拿大和墨西哥 |
|
涵盖的市场参与者 |
Getinge、SKAN AG、Hosokawa micron ltd、Gelman Singapore、Azbil Corporation、Germfree Laboratories, Inc.、M. Braun Inertgas-Systeme Gmbh、Nuaire、Iteco SRL、Comecer SPA、Hecht Technologie Gmbh、Steriline SRL、Envair Limited、Tema Sinergie SPA、Schematic Engineering Industries、Chiyoda Corporation、Chamunda Pharma Machinery Pvt. Ltd、Bioquell (Ecolab Solution)、Jacomex、Fedegari Autoclavi SpA、LAF Technologies、ISO Tech Design、Cytiva、Esco Pharma 等等。 |
北美制药隔离器市场定义
隔离概念在制药行业中广为人知，它保护工艺不受操作员影响，或保护操作员不受工艺影响，同时保护环境。控制的关键是将暴露降至最低。通过将暴露范围控制在化合物的危险水平以下，操作员和环境得到适当保护。因此，产品得到保护，并因此解决了一个关键的监管问题。制药隔离器是一种密封的细菌外壳，用于制药环境中的无菌灌装和毒性工艺。它由一个完全无菌的主隔离器制成，产品在其中使用放在其中一面墙上的齐肩手套进行处理、储存或包装。制药隔离器可以控制和控制制药过程。制药隔离器工作所需的条件是无菌环境，无活微生物。制药隔离器确保生产区域和无菌环境处于不同的位置。与无菌环境中的制药行业洁净室相比，制药行业隔离器具有成本效益和效率。它通过调整隔离器和限制进入屏障所需的不同标准认证标准，在微生物和药物生产过程中创造受控气氛。它同时确保对产品、操作人员和环境的保护。
制药隔离器用途广泛，可根据生产和控制目的而变化。它用于处理、转移或包装固体、半固体或粉末药物，处理和灌装溶液和输液。制药隔离器用于无菌测试、组织或生物生产系统或致病样品的无菌处理等。它可用于药物和医药产品的生产和控制。制药和生物技术行业对隔离器的需求激增，以及低运营成本、药品生产中对无菌条件的高维护以及生物制药行业的需求不断增长，这些因素预计将在预测期内推动市场增长。
此外，市场参与者的战略主动性、药物隔离器的技术进步、高无菌保证以及对医疗保健基础设施的不断增加的投资。这些因素增加了对药物隔离器市场的需求。
北美制药隔离器市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
蓬勃发展的制药行业对药物隔离器的需求不断增长
药物隔离器是一种隔离设备，用于将药物操作或活动与操作员和周围环境分开。它可用于多种用途，例如：
- 为某项活动或程序提供分类的无菌环境，并保护其免受来自操作员和相邻环境的微生物和非微生物污染，这称为产品保护。
- 保护产品免受其他产品和程序产生的污染，以及同时或之前操作产生的污染。这被称为防止方法产生的污染或交叉污染的保障。
使用隔离器的制造单元中的污染问题日益严重，从而产生了对有助于污染和去污染的制药隔离器的需求。
- 药物隔离器的运行成本低
密封在密封性达到一定标准的封闭空间内，包含内部合格的受控环境，隔离器的应用范围从药品生产的研发到实验室使用，尤其是用于微生物质量控制。而药品无菌生产对洁净度的要求极高，无菌生产环境几乎完全无颗粒、无菌。
由于制药行业的发展和产品范围的扩大，越来越多的制造商和供应商需要考虑对洁净室技术的最新附加技术进行投资。
药品的无菌处理是符合政府法规的良好生产规范中需要纳入的主要因素。洁净室技术维持无菌条件的成本比制药隔离器高出约 62%，这迫使制造商购买隔离器技术，并制约了药品的总体制造成本。
克制
严格的政府法规
活性药物成分 (API) 和制药中间体（例如生物药物、放射性药物和药物）以及用于生产临床试验药物的药物受《食品和药品法规》第 1A 和 2 分部 C 部分的监管。
- 《食品和药品管理法规》第 1A 部分 C 部分描述了需要遵守良好生产规范 (GMP) 的活动，并且必须在颁发 API 机构许可证 (EL) 之前证明这些活动。
- 《食品和药品法规》第 C 部分第 2 章规定了 API 和 API 中间体的 GMP 要求，本指导文件对其进行了解释。
由于政府的严格规定，生产必须遵守活性药物成分 (API) - (GUI-0104) 的良好生产规范 (GMP) 指南，从而限制了市场增长率。
机会
-
市场参与者的战略举措
制药隔离器市场的崛起增加了对战略商业理念的需求。它包括合作伙伴关系、业务扩展和其他发展。对药品的需求不断增长，大大增加了对辅料的需求，为了应对这种需求，公司正在建设新的生产基地以及其他战略举措。
主要市场参与者的产品发布、协议和业务扩展等战略举措将推动医药隔离器市场的增长，并有望为北美医疗显示器市场带来机遇。
挑战
缺乏专业技能
缺乏专业技能将影响一个地方的复苏和增长速度。通常，一个地方失业的人拥有其他地方所缺乏的技能。此外，该领域的快速技术进步也导致缺乏专业知识。
缺乏熟练的专业人员来处理药物隔离器对选择和开发药物隔离器提出了重大挑战。Phys.org 2003 的数据提到，由于亚太地区对药物隔离器的需求增加以及 LED 和 LCD 显示器中使用的微芯片严重短缺，医疗显示器行业正面临工人短缺的问题，这增加了 LCD 生产的价格交付周期。
由于对技能的要求过高，留住和管理技能型专业人员已成为一项挑战。此外，技术进步是导致对熟练专业人员需求增加的另一个方面。神经科医生报告说，他们的中心存在大量未满足的支持性护理需求和障碍，只有少数人认为自己有能力提供支持性护理。迫切需要对神经科医生和专业人员进行痴呆症治疗教育，并采购可用的支持性护理资源。缺乏训练有素、经验丰富的专业人员和持续的技能差距限制了就业前景和获得优质工作的机会。因此，显然，缺乏具备足够技能的专业人员将对市场增长构成挑战。
COVID-19 对北美制药隔离器市场的影响
COVID-19 疫情已成为全球最严重的威胁。它给全球许多商店和企业造成了严重破坏。另一方面，疫情也为制药和生物制药公司扩大研发活动以开发针对新冠病毒的新疫苗提供了许多机会。各公司正在进行临床试验，试图阻止 COVID-19 病毒的传播。随着临床试验数量的增加，生物制药组织的制药绝缘体供应商拥有更多机会。
制造商正在制定各种战略决策，以在新冠疫情后实现复苏。参与者正在进行多项研发活动、产品发布和战略合作，以改进医药医疗显示器市场所涉及的技术和测试结果。
最新动态
- 2022 年 6 月，该公司宣布与医疗供应公司 (MSC) 建立合作伙伴关系，为爱尔兰的制药和制药行业销售和维修 Jacomex 设备。MSC 在市场上拥有多年公认的专业知识，现场团队最接近客户，公司目前在国外工作的商业团队很高兴欢迎 Cian Murphy 并最终确定 Jacomex 和 MSC 之间的协议。这是长期富有成效的合作的开始。这有助于公司扩大业务。
- 2022 年 1 月，Clario 与放射性药物生产和正电子发射断层扫描 (PET) 收购公司 XingImaging 合作，在中国开展 PET 成像临床试验，以测试新型疗法。此次合作旨在共享 Clario 和 XingImaging 的联合资源和神经科学专家，以加快在中国开展临床试验和药物研发。
北美制药隔离器市场范围
北美医药隔离器市场细分为类型、压力、应用、配置、系统类型、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
北美制药隔离器市场（按类型划分）
- 无菌隔离器
- 安全壳隔离器
- 生物隔离器
- 取样和称重隔离器
- 活性药物成分(API) 制造隔离器
- 放射性药物隔离器
- 生产隔离器
- 其他的
根据类型，北美制药隔离器市场分为无菌隔离器、密闭隔离器、生物隔离器、取样和称重隔离器、活性药物成分 (API) 制造隔离器、放射性药物隔离器、生产隔离器等。
北美制药隔离器市场（按系统类型划分）
- 封闭系统
- 开放系统
根据系统类型，北美制药隔离器市场分为封闭系统和开放系统。
北美制药隔离器市场，按压力
- 正压
- 负压
根据压力，北美制药隔离器市场分为正压和负压。
北美制药隔离器市场（按配置）
- 落地式
- 模块化的
- 移动的
- 袖珍的
- 桌面
- 便携的
- 其他的
根据配置，北美制药隔离器市场分为落地式、模块化、移动式、紧凑式、台式、便携式和其他。
北美医药隔离器市场（按应用划分）
- 无菌检测
- 制造业
- 取样/称重/分配
- 医疗器械制造
- 其他的
根据应用，北美制药隔离器市场细分为无菌测试、制造、采样/称重/分销、医疗器械制造等。
北美药品隔离器市场（按最终用户划分）
- 医院
- 诊断实验室
- 学术和研究机构
- 制药和生物技术公司
- 合同研究组织
- 其他的
根据最终用户，北美制药隔离器市场分为医院、诊断实验室、学术和研究机构、制药和生物技术公司、合同研究组织等。
北美药品隔离器市场，按分销渠道划分
- 直接招标
- 零售销售
- 第三方分销商
根据分销渠道，北美医药隔离器市场分为直接招标、零售、第三方分销商。
北美制药隔离器市场区域分析/见解
对北美医药隔离器市场进行了分析，并提供了市场规模信息，包括类型、压力、应用、配置、系统类型、最终用户和分销渠道。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。2022 年，美国将占据主导地位，因为美国是最大的消费市场，拥有主要市场参与者，GDP 较高，农业领域的技术进步不断提升。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。
竞争格局和北美制药隔离器市场份额分析
北美制药隔离器市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对北美制药隔离器市场的关注有关。
北美制药隔离器市场的一些主要参与者包括 Getinge、SKAN AG、Hosokawa micron ltd、Gelman Singapore、Azbil Corporation、Germfree Laboratories, Inc.、M. Braun Inertgas-Systeme Gmbh、Nuaire、Iteco SRL、Comecer SPA、Hecht Technologie Gmbh、Steriline SRL、Envair Limited、Tema Sinergie SPA、Schematic Engineering Industries、Chiyoda Corporation、Chamunda Pharma Machinery Pvt. Ltd、Bioquell (Ecolab Solution)、Jacomex、Fedegari Autoclavi SpA、LAF Technologies、ISO Tech Design、Cytiva、Esco Pharma。
研究方法：北美制药隔离器市场
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、北美与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 INDUSTRIAL INSIGHTS:
5 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL
6.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS
6.1.3 HIGH MAINTENANCE OF ASEPTIC CONDITIONS IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS
6.1.4 LOW OPERATING COST OF PHARMACEUTICAL ISOLATORS & GROWING DEMAND IN THE BIOPHARMACEUTICAL INDUSTRY
6.2 RESTRAINTS
6.2.1 STRINGENT GOVERNMENTAL REGULATIONS
6.2.2 HIGH COST OF INSTALLATION & LIMITED ADOPTION OF RABS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS
6.3.3 HIGH STERILITY ASSURANCE
6.4 CHALLENGES
6.4.1 LACK OF SKILLED EXPERTISE
6.4.2 ENGINEERING CHALLENGES FACED WHILE DESIGNING THE PHARMACEUTICAL ISOLATORS
7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE
7.1 OVERVIEW
7.2 ASEPTIC ISOLATOR
7.3 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
7.4 CONTAINMENT ISOLATORS
7.5 BIO ISOLATORS
7.6 SAMPLING AND WEIGHING ISOLATORS
7.7 RADIOPHARMACEUTICAL ISOLATORS
7.8 PRODUCTION ISOLATORS
7.9 OTHERS
8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE
8.1 OVERVIEW
8.2 OPEN SYSTEM
8.3 CLOSED SYSTEM
9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE
9.1 OVERVIEW
9.2 POSITIVE PRESSURE
9.3 NEGATIVE PRESSURE
10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION
10.1 OVERVIEW
10.2 FLOOR STANDING
10.3 MODULAR
10.4 MOBILE
10.5 COMPACT
10.6 TABLE TOP
10.7 PORTABLE
10.8 OTHERS
11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 STERILITY TESTING
11.3 MANUFACTURING
11.4 SAMPLING/WEIGHING/DISTRIBUTION
11.5 MEDICAL DEVICE MANUFACTURING
12 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 THIRD PARTY DISTRIBUTORS
13 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER
13.1 OVERVIEW
13.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
13.2.1 STERILE FILTERING
13.2.2 AMPULE FILLING
13.2.3 SYRINGE FILLING
13.2.4 SAMPLING
13.2.5 SAMPLE TESTING
13.2.6 STERILITY TESTING
13.2.7 PACKAGING
13.2.8 OTHERS
13.3 CONTRACT RESEARCH ORGANIZATION
13.3.1 STERILE FILTERING
13.3.2 AMPULE FILLING
13.3.3 SYRINGE FILLING
13.3.4 SAMPLING
13.3.5 SAMPLE TESTING
13.3.6 STERILITY TESTING
13.3.7 PACKAGING
13.3.8 OTHERS
13.4 ACADEMIC AND RESEARCH INSTITUTES
13.4.1 STERILE FILTERING
13.4.2 AMPULE FILLING
13.4.3 SYRINGE FILLING
13.4.4 SAMPLING
13.4.5 SAMPLE TESTING
13.4.6 STERILITY TESTING
13.4.7 PACKAGING
13.4.8 OTHERS
13.5 HOSPITALS
13.5.1 STERILE FILTERING
13.5.2 AMPULE FILLING
13.5.3 SYRINGE FILLING
13.5.4 SAMPLING
13.5.5 SAMPLE TESTING
13.5.6 STERILITY TESTING
13.5.7 PACKAGING
13.5.8 OTHERS
13.6 DIAGNOSTIC LABORATORIES
13.6.1 STERILE FILTERING
13.6.2 AMPULE FILLING
13.6.3 SYRINGE FILLING
13.6.4 SAMPLING
13.6.5 SAMPLE TESTING
13.6.6 STERILITY TESTING
13.6.7 PACKAGING
13.6.8 OTHERS
13.7 OTHERS
14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 GETINGE AB
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 AZBIL CORPORATION
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 CHIYODA CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 HOSOKAWA MICRON LTD
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BIOQUELL, AN ECOLAB SOLUTION (A SUBSIDIARY OF ECOLAB)
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 CHAMUNDA PHARMA MACHNIERY
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 COMECER S.P.A. (A SUBSIDIARY OF ATS AUTOMATION TOOLS) (2021)
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 ENVAIR TECHNOLOGY
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 ESCO MICRO PTE. LTD
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 FEDEGARI AUTOCLAVI S.P.A
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 GERMFREE LABORATORIES, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 GELMAN SINGAPORE
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 HECT TECHNOLOGIE GMBH (2021)
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 ISO TECH DESIGN
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 ITECO SRL
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 JACOMEX
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 LAF TECHNOLOGIES
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MBRAUN.(2021)
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 NUAIRE (A SUBSIDIARY OF GENUIT GROUP PLC)
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 STERILINE (2021)
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 SCHEMATIC ENGINEERING INDUSTRY
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENTS
17.23 SKAN AG
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 TEMA SINERGIE S.P.A
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR
TABLE 2 APPLICATION OF GUI-0104 TO API MANUFACTURING
TABLE 3 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA ASEPTIC ISOLATOR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA RADIOPHARMACEUTICAL ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA PRODUCTION ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA SAMPLING/WEIGHING/DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA RETAIL SALES INPHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA DIAGNOSTIC LABARATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA DIAGNOSTICS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 60 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 61 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 62 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 63 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 64 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 66 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 67 U.S. CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 68 U.S. ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 69 U.S. HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 U.S. DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 71 U.S. PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 74 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 75 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 76 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 77 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 79 CANADA CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 80 CANADA ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 81 CANADA HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 82 CANADA DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 83 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 84 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 85 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2020-2029 (USD MILLION)
TABLE 86 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE, 2020-2029 (USD MILLION)
TABLE 87 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2020-2029 (USD MILLION)
TABLE 88 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 90 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 91 MEXICO CONTRACT RESEARCH ORGANIZATIONS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 MEXICO ACADEMIC RESEARCH & INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 93 MEXICO HOSPITALS LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 94 MEXICO DIAGNOSTICS IN PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 95 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION
FIGURE 11 INCREASING USE OF PHARMACEUTICAL ISOLATORS IS EXPECTED TO DRIVE THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 ASEPTIC ISOLATORS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET
FIGURE 14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, 2021
FIGURE 15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2021
FIGURE 19 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, 2021
FIGURE 23 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2021
FIGURE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, LIFELINE CURVE
FIGURE 30 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2021
FIGURE 31 NORTH AMERICAPHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 NORTH AMERICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 NORTH AMERICAPHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, 2021
FIGURE 39 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 40 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, CAGR (2022-2029)
FIGURE 41 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET : BY END USER, LIFELINE CURVE
FIGURE 42 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2021)
FIGURE 43 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2021)
FIGURE 44 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: TYPE (2022-2029)
FIGURE 47 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
